Enhanced light sensitivity may worsen Alzheimer’s symptoms

FHS
July 28, 2023
6:53 am

New Alzheimer’s research from UVA Health suggests that enhanced light sensitivity may contribute to “sundowning” – the worsening of symptoms late in the day – and spur sleep disruptions thought to contribute to the disease’s progression.

Risk Adjusted Net Present Value: What is the current valuation of Aslan Pharmaceuticals’s Eblasakimab

The revenue for Eblasakimab is expected to reach an annual total of $430 mn by 2038 in the US based off GlobalDatas Expiry Model. The

September 8, 2024

Why Novartis is changing the name of its research labs

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy. The hub, which is headquartered in Cambridge, Mass.,

September 8, 2023

Genetic study demonstrates fat-selective weight loss with GLP-1 agonist use

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type

February 25, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.